CorVista’s AI-based pulmonary capillary wedge pressure add-on test represents the third FDA clearance for its cardiopulmonary ...

Patient being positioned for MR study of the head and abdomen. — Image by Ptrump16. CC BY-SA 4.0 The company TeraRecon, who develop medical imaging advanced visualization, clinical AI, and workflow ...

Cardiovascular disease is becoming increasingly common among people ages 20–29, according to the World Health Organization, ...

LOS ANGELES--(BUSINESS WIRE)--Sensydia, a medical technology company pioneering non-invasive cardiac assessment, today announced that the first patient has been enrolled in its multi-center pivotal ...

Completion of this 50-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate measurement of pulmonary pressure. LOS ANGELES--(BUSINESS ...

Researchers used advanced machine learning to increase the accuracy of a national cardiovascular risk calculator while preserving its interpretability and original risk associations. Risk calculators ...

The patient–doctor relationship is built upon trust in not only doctors' knowledge and skills but also attitudes. Over time, notions of trust in medical education have focused increasingly on trainees ...

Please provide your email address to receive an email when new articles are posted on . In adults being evaluated for cardiac function by echocardiography, an initial assessment of left ventricular ...

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ...